Home
James Kihara, Principal Accounting Officer: Acadia Pharmaceuticals ACAD Sell · Filed 24/11/19
Trade details
- Type
- Insider sale
- Amount
- $68,467.13
- Shares · price
- 4,073 sh · $16.81 a share
- Held after
- 19,863 sh
- Trade date
- 24/11/19
- Filed
- 24/11/19
- Days to filing
- 0 days
Sold 17.0% of holdings
- Share of holding sold
- 17.0%
Acadia Pharmaceuticals trades, last 26 weeks
What else happened in Acadia Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/10/20~24/12/19James Kihara's recent trades
- James Kihara
Sell10b5-1 planAcadia Pharmaceuticals
Sell10b5-1 planAcadia Pharmaceuticals
ACAD
$297.9K
11,421 sh
$297.9K
Filed 06/29
Traded 06/26
- James Kihara
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 planAcadia Pharmaceuticals
ACAD
$297K
11,421 sh
$297K
Filed 06/26
Traded 06/26
- James Kihara
SellAcadia Pharmaceuticals
SellAcadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/27
Traded 05/26
- James Kihara
Planned saleAcadia Pharmaceuticals
Planned saleAcadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/26
Traded 05/26
- James Kihara
SellAcadia Pharmaceuticals
SellAcadia Pharmaceuticals
ACAD
$29K
1,332 sh
$29K
Filed 05/05
Traded 05/04